机构:[1]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, London WC1N 3BG, England;[2]Capital Med Univ, WHO Collaborating Ctr Res & Training Neurosci, Beijing Neurosurg Inst, Beijing, Peoples R China;研究所北京市神经外科研究所首都医科大学附属天坛医院[3]Universal Love Hosp, Mudanjiang, Heilongjiang Pr, Peoples R China;[4]Subei Peoples Hosp, Dept Neurol, Yangzhou, Jiangsu Prov, Peoples R China;苏北人民医院[5]Fudan Univ, Inst Neurol, Shanghai 200433, Peoples R China;[6]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China;[7]WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland;[8]SEIN, WHO Collaborating Ctr Res Training & Treatment Ep, Epilepsy Inst Netherlands Fdn, Achterweg, Heemstede, Netherlands;[9]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, Queen Sq, London WC1N 3BG, England
Objective The Global Campaign Against Epilepsy demonstration project in rural China aimed: to reduce the treatment gap and morbidity of people with epilepsy by using community-level interventions; to train and educate health professionals; to dispel stigma; to identify potential for prevention and to develop models of integration of epilepsy control into the local health systems. We report the overall results of the demonstration project, focusing on the prevalence and the change in the treatment gap of epilepsy after an intervention. Methods Door-to-door epidemiological surveys were carried out before, and 6 months after the end of, an intervention project for epilepsy in rural settings in five provinces of China. The intervention consisted of a treatment programme available to patients without prior appropriate treatment and a public health educational programme about epilepsy. The sampled population in the second survey was 51 644 people. Findings In the second survey, epilepsy was confirmed in 320 people, yielding a lifetime prevalence of 6.2/1000 and a prevalence of active epilepsy of 4.5/1000. The lifetime prevalence and prevalence of active epilepsy in the first survey were 7.0/1000 and 4.6/1000, respectively. The treatment gap of active epilepsy in the second survey was 49.8%, 12.8 percentage points lower than that of the first survey (62.6%). Conclusion The results of this study suggest that the intervention measures used were possibly effective and evidently feasible in rural China, contributing to a decrease in the treatment gap of epilepsy.
基金:
Chinese Ministry of Health; WHOWorld Health Organization
第一作者机构:[2]Capital Med Univ, WHO Collaborating Ctr Res & Training Neurosci, Beijing Neurosurg Inst, Beijing, Peoples R China;
通讯作者:
通讯机构:[1]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, London WC1N 3BG, England;[9]UCL Inst Neurol, Univ Dept Clin & Expt Epilepsy, WHO Collaborating Ctr Res & Training Neurosci, Queen Sq, London WC1N 3BG, England
推荐引用方式(GB/T 7714):
Wang Wenzhi,Wu Jianzhong,Dai Xiuying,et al.Global campaign against epilepsy: assessment of a demonstration project in rural China[J].BULLETIN OF THE WORLD HEALTH ORGANIZATION.2008,86(12):964-969.doi:10.2471/BLT.07.047050.
APA:
Wang, Wenzhi,Wu, Jianzhong,Dai, Xiuying,Ma, Guangyu,Yang, Bin...&Sander, Josemir W..(2008).Global campaign against epilepsy: assessment of a demonstration project in rural China.BULLETIN OF THE WORLD HEALTH ORGANIZATION,86,(12)
MLA:
Wang, Wenzhi,et al."Global campaign against epilepsy: assessment of a demonstration project in rural China".BULLETIN OF THE WORLD HEALTH ORGANIZATION 86..12(2008):964-969